We've also got a look at genetic testing company 23andMe .In this podcast, Motley Fool analyst Jason Moser and host Mary Long discuss the semiconductor supply chain, ASML's earnings, and what's ailing the pharmacy industry.Then, Motley Fool contributor Brian Orelli joins for a look at how genetic testing company 23andMe went from a $6 billion valuation to a penny stock in a mere three years...and where the company (and its data) might go from here.To catch full episodes of all The Motley Fool's free podcast ...